Gerresheimer AG (ETR:GXI – Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as €73.85 ($78.56) and last traded at €75.20 ($80.00), with a volume of 125943 shares traded. The stock had previously closed at €74.15 ($78.88).
Gerresheimer Price Performance
The stock’s 50 day moving average is €88.02 and its two-hundred day moving average is €95.72. The company has a debt-to-equity ratio of 79.36, a current ratio of 0.87 and a quick ratio of 0.40. The stock has a market capitalization of $2.60 billion, a PE ratio of 22.33, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Featured Articles
- Five stocks we like better than Gerresheimer
- How to invest in marijuana stocks in 7 steps
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- 3 Stocks to Consider Buying in October
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.